Want to see AU:EDE full AI Analyst Report?
Top Page
Eden Innovations
(Sydney:EDE)
Select Model
Select Model
Rating:39Underperform
Price Target:
AU$0.09
▼(-15.00% Downside)
Action:Reiterated
Date:07/10/26
The score is driven primarily by very weak financial performance (declining revenue, substantial losses, negative equity, and negative operating/free cash flow). Technicals are also bearish with price below key moving averages and negative MACD, despite oversold readings. Valuation offers limited support because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Gross Margin
A 68.95% gross profit margin indicates strong unit economics at the cost-of-goods level. Structurally this provides scope to cover fixed costs and, if SG&A is controlled, supports a durable path back to operating profitability as revenue stabilizes.
Negative Factors
Negative Equity
Negative equity of -1.75M signals balance-sheet stress and potential insolvency risk. This high leverage constrains financing options, raises refinancing and covenant risks, and materially limits strategic flexibility to invest or withstand further revenue volatility over coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross Margin
A 68.95% gross profit margin indicates strong unit economics at the cost-of-goods level. Structurally this provides scope to cover fixed costs and, if SG&A is controlled, supports a durable path back to operating profitability as revenue stabilizes.
Read all positive factors
Eden Innovations (EDE) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$61.11M
Dividend YieldN/A
Average Volume (3M)1.01M
Price to Earnings (P/E)―
Beta (1Y)0.95
Revenue Growth-9.36%
EPS Growth54.49%
CountryAU
Employees35
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding611,130,200
10 Day Avg. Volume807,653
30 Day Avg. Volume1,006,652
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-4.66
Price to Sales (P/S)3.35
P/FCF Ratio-2.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Eden Innovations Business Overview & Revenue Model
Company Description
Eden Innovations Ltd specializes in providing environmentally conscious technological solutions. The company is involved in the creation, production, and sales of several key products, including EdenCrete, a concrete admixture enhanced with carbon...
How the Company Makes Money
null...
Eden Innovations Financial Statement Overview
Summary
Income Statement
20
Very Negative
Balance Sheet
15
Very Negative
Cash Flow
25
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.69M | 2.43M | 2.02M | 4.70M | 4.15M | 3.28M |
| Gross Profit | -696.84K | 1.68M | 1.39M | -2.17M | -3.36M | -3.10M |
| EBITDA | -2.84M | -3.93M | -4.83M | -15.08M | -4.49M | -3.73M |
| Net Income | -330.41K | -6.93M | -7.55M | -17.87M | -6.65M | -5.76M |
Balance Sheet | ||||||
| Total Assets | 17.99M | 17.84M | 19.07M | 17.00M | 25.79M | 24.48M |
| Cash, Cash Equivalents and Short-Term Investments | 3.66M | 561.18K | 975.20K | 2.53M | 1.55M | 2.18M |
| Total Debt | 3.89M | 16.34M | 12.79M | 10.21M | 4.91M | 5.26M |
| Total Liabilities | 6.63M | 19.59M | 15.10M | 12.28M | 6.30M | 6.34M |
| Stockholders Equity | 11.36M | -1.75M | 3.98M | 4.73M | 19.49M | 18.14M |
Cash Flow | ||||||
| Free Cash Flow | -3.18M | -3.70M | -5.27M | -5.11M | -7.51M | -7.46M |
| Operating Cash Flow | -3.18M | -3.70M | -5.22M | -4.17M | -6.03M | -5.55M |
| Investing Cash Flow | 6.34M | -305.20K | -586.79K | -940.93K | -1.48M | -1.91M |
| Financing Cash Flow | 1.01M | 3.59M | 4.26M | 6.09M | 6.78M | 8.45M |
Eden Innovations Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | AU$38.05M | 10.75 | 6.56% | ― | 9.57% | -21.00% | |
54 Neutral | AU$5.24B | 43.49 | 3.98% | 2.74% | 7.67% | -22.90% | |
53 Neutral | AU$31.38M | -14.33 | -15.66% | ― | 20.05% | 33.33% | |
49 Neutral | AU$48.44M | -8.13 | -38.77% | ― | ― | 31.86% | |
42 Neutral | AU$3.75M | -1.15 | -41.16% | ― | 308.85% | -44.44% | |
39 Underperform | AU$61.11M | -13.51 | -6.88% | ― | -9.36% | 54.49% |
* Industrials Sector Average
AU:EDE
Eden Innovations
0.10
0.06
175.00%
AU:PET
Phoslock Environmental Technologies Limited
0.01
-0.01
-50.00%
AU:CWY
Cleanaway Waste Management
2.37
-0.44
-15.57%
AU:EGL
Environmental Group Limited
0.11
-0.16
-60.38%
AU:ECT
Environmental Clean Technologies Limited
0.13
0.08
150.00%
AU:DEM
De.mem Ltd.
0.11
-0.02
-12.50%
Eden Innovations Corporate Events
Eden Innovations Issues Shares to Settle Director Fees and Loans
Aug 4, 2026
Eden Innovations Ltd is an Australia-based company listed on the ASX under the ticker EDE, operating in the industrial technology and materials sector. The company focuses on developing and commercialising innovative products and solutions, with i...
Eden Innovations Issues 21 Million Unquoted Performance Rights Under Incentive Scheme
Aug 4, 2026
Eden Innovations Ltd has announced the issuance of 21,000,000 unquoted Performance Rights, expiring on 4 August 2029, under its employee incentive scheme. The move reinforces the company’s use of long-term equity incentives to align employee...
Eden Innovations Issues 3 Million Unquoted Options in Strategic Equity Move
Aug 4, 2026
Eden Innovations Ltd has issued 3 million unquoted options in three equal tranches, each with different exercise prices of $0.20, $0.30 and $0.40, all expiring on 4 August 2028. The options form part of previously announced transactions and are no...
Eden Innovations Issues Large Tranche of Unquoted Options and Performance Rights
Aug 4, 2026
Eden Innovations has issued a significant tranche of unquoted equity securities, comprising 10 million unlisted options exercisable at $0.25 expiring in August 2029, 25 million unlisted options exercisable at $0.35 expiring in August 2030, and 5 m...
Eden Innovations Issues 71.25 Million New Unlisted Options
Aug 4, 2026
Eden Innovations Ltd, an ASX-listed entity under ticker EDE, has filed a notification regarding changes to its unquoted equity securities. The release is focused on the company’s capital management actions, with no further details on its ope...
Eden Innovations Seeks ASX Quotation for Over 20 Million New Shares
Aug 4, 2026
Eden Innovations Ltd, listed on the ASX under the code EDE, operates in the innovation-driven technology space and raises equity capital through ordinary fully paid shares. Its focus on commercialising new solutions is underpinned by regular acces...
Eden Innovations Seeks ASX Quotation for Additional Ordinary Shares
Aug 3, 2026
Eden Innovations Ltd has applied for quotation on the ASX of 34,669 ordinary fully paid shares, to be issued on 3 August 2026. The new securities arise from the exercise or conversion of existing options or other convertible instruments, slightly ...
Eden Innovations ramps up EdenCrete rollout and enters FY2027 debt-free
Jul 31, 2026
Eden Innovations reported strong quarterly progress, driven by accelerating adoption of its EdenCrete Pz7 dosage systems across North American ready-mix concrete plants and expansion into new U.S. states, Canada, and ongoing trials in India and ot...
Eden Innovations Wins Strong Shareholder Backing for Capital and Incentive Resolutions
Jul 24, 2026
Eden Innovations has reported that all resolutions put to shareholders at its 24 July 2026 general meeting were passed by poll without amendment, signalling strong investor support for recent capital management initiatives. The approvals cover rat...
Eden Innovations Expands EdenCrete Pz7 Reach Across North American Amrize Plants
Jul 22, 2026
Eden Innovations is extending its EdenCrete Pz7 footprint in North America via new installations at Amrize concrete plants in Texas, Minnesota and the greater Toronto area. The advanced admixture, designed to boost concrete strength and enable cem...
Eden Innovations Wins Strong Endorsement in Indian Government Concrete Trials
Jul 22, 2026
Eden Innovations reported positive results from Indian government-led trials of its EdenCrete Pz7 concrete additive, conducted by the Central Road Research Institute in Delhi on mixes used for new highways and thin concrete overlays. The carbon na...
UBS Drops Below Substantial Holder Threshold in Eden Innovations
Jul 6, 2026
Eden Innovations Ltd operates in the technology and innovation sector, focusing on the development and commercialization of advanced materials and related solutions. The company is listed in Australia and its shareholder base includes institutiona...
Eden Innovations Sets July 2026 General Meeting and Moves Further Online With Shareholder Communications
Jun 25, 2026
Eden Innovations Ltd has scheduled a General Meeting of shareholders to be held in person at the company’s Perth offices on 24 July 2026 at 11:00 a.m. AWST, with the formal Notice of Meeting and Explanatory Memorandum made available online v...
UBS Group exits substantial holding in Eden Innovations
Jun 24, 2026
UBS Group AG and its related bodies corporate have notified Eden Innovations that they ceased to be a substantial shareholder in the company as of 22 June 2026. The change, formalised in a statutory Form 605 notice signed on 24 June 2026, indicate...
Eden Innovations Reports Strong EdenCrete Trials in India’s Booming Concrete Market
Jun 22, 2026
Eden Innovations reported strong trial results for its EdenCrete Pz7 additive in India’s concrete market, with tests in the Delhi region showing higher strength and abrasion resistance at low dosages in both road and high-strength mixes. The...
Eden Innovations Seeks Quotation for New Share Issue on ASX
Jun 19, 2026
Eden Innovations Ltd has applied to the ASX for quotation of 693,736 new ordinary fully paid shares, to be issued on 19 June 2026. The additional securities arise from the exercise or conversion of existing options or other convertible instruments...
Eden Innovations Completes Final Tranche of $4 Million Share Placement
Jun 9, 2026
Eden Innovations has completed the second and final tranche of its institution-led capital raising, issuing 14,166,666 fully paid ordinary shares at $0.18 each to secure $2.55 million before costs. This brings the total placement to $4 million and...
Eden Innovations Seeks Quotation for Second Tranche of Placement Shares
Jun 9, 2026
Eden Innovations has applied to the ASX for quotation of 14,166,666 new ordinary fully paid shares, representing the second tranche of a placement previously announced in April 2026. The additional capital from this placement is expected to suppor...
Eden Innovations Seeks ASX Quotation for Over 5 Million New Shares
Jun 1, 2026
Eden Innovations Ltd has applied for quotation on the ASX of 5,092,561 new ordinary fully paid shares, with an issue date of 1 June 2026. The move modestly expands the company’s listed share capital and may provide additional liquidity for s...
Eden Innovations Plans New Options and Performance Rights Issue
May 22, 2026
Eden Innovations has lodged details of a proposed issue of securities with the ASX, outlining plans to issue up to 10 million unlisted options exercisable at $0.25, 25 million unlisted options exercisable at $0.35, and 5 million performance rights...
Eden Innovations Taps Tony G to Lead EdenShield’s European Expansion
May 21, 2026
Eden Innovations has appointed former European Parliament member and prominent technology investor Antanas Guoga, also known as Tony G, as Head of EdenShield Europe to drive its expansion across European defence, government and critical infrastruc...
Eden Innovations Issues New Shares and Options Under Disclosure Exemptions
May 12, 2026
Eden Innovations has issued 3,823,349 fully paid ordinary shares following the exercise of an equivalent number of options, including 357,143 shares allocated to a sophisticated investor under a prior shortfall offer. The company also confirmed th...
Eden Innovations Lists 3.8 Million New Shares on ASX
May 12, 2026
Eden Innovations Ltd has applied for quotation on the ASX of 3,823,349 new ordinary fully paid shares, effective 12 May 2026, under its existing ticker EDE. The additional securities arise from the exercise of options or conversion of other securi...
Eden Innovations Showcases Advanced Materials for Defense and Infrastructure
May 8, 2026
Eden Innovations is highlighting its portfolio of advanced materials and energy systems tailored for defense and critical infrastructure applications, underscoring products like EdenCrete, EdenCrete Pz7, and its CNT technology platform. The compan...
Eden Innovations links share price move to EdenShield interest, denies undisclosed news
May 8, 2026
Eden Innovations has told the Australian Securities Exchange it is not aware of any undisclosed information that would explain a recent rise in its share price from $0.17 to $0.22. The company reaffirmed its compliance with continuous disclosure o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.